SCHEMBL17299517

SCHEMBL17299517

c1ccc(-n2c3ccccc3c3ccc4ccc5c6cc(-n7c8ccccc8c8ccccc87)ccc6oc5c4c32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
ATM Q13315 1/20 0.43
ALDH1A1 P00352 3/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
BRCA1 P38398 1/20 0.39
KMT2A Q03164 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
PPARG P37231 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
NR2E3 Q9Y5X4 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GLA P06280 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17299562 0.94 KDM4E (0.37) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL17299493 0.93 SIRT2 (0.37) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL17299570 0.88 SIRT2 (0.35) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL17990261 0.88 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL25098388 0.88 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL9890217 0.86 KDM4E (0.46) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL17299482 0.86 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL17299465 0.85 KDM4E (0.40) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL17990667 0.85 ALDH1A1 (0.36) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL26472477 0.85 KDM4E (0.53) KDM4EL3MBTL1ATMALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10003031-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2018-06-19 US disclosed
US-10003031-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2018-06-19 US disclosed
US-20150349276-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2015-12-03 US disclosed
US-20150349276-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150349276-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF ORAI2, ESR1, OR10J3 KDM4E 636/4885L3MBTL1 569/4885ATM 2097/4885
US-10003031-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof ORAI2, ESR1, OR10J3 KDM4E 636/4885L3MBTL1 569/4885ATM 2097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.